Anti-Human CD22 (IB14) Antibody

Human

CD22

1.0 - 5.0 mg/ml

Human IgG1 (E356D/M358L)-kappa

0.1mg

P20273

Blue ice

CD22 (Siglec-2) is an inhibitory co-receptor on B cells that fine-tunes B-cell receptor signalling and is a frequently studied marker in B-cell biology and lymphoma research. Clone IB14 is a human IgG1 monoclonal antibody recognising human CD22 and is suitable for functional assays exploring B-cell signalling and antigen engagement. Anti-CD22 clone IB14 is prepared in a low-endotoxin format compatible with in vivo use and is manufactured in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Supplied for research use only as a non-therapeutic reagent, IB14 offers consistent, reproducible performance for human B-cell immunology studies.

Sialic acid binding Ig-like lectin 2, SIGLEC2, SIGLEC-2, B-lymphocyte cell adhesion molecule, BL-CAM, Leu-14

IB14

Detects human CD22

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –20°C or –80°C. Avoid Repeated Freeze Thaw Cycles.

This antibody is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.